12:00 AM
Jul 13, 2009
 |  BC Week In Review  |  Company News  |  Deals

Apoptos, Receptos deal

Receptos acquired cancer company Apoptos for an undisclosed sum. Apoptos develops small molecules...

Read the full 45 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >